Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-16

Clinical Trial Update: Double Blind Study of Hypertonic Saline vs Mannitol in the Management of Increased Intracranial Pressure (ICP). [NA]

View source ↗

Summary

A clinical trial comparing hypertonic saline versus mannitol for the management of elevated intracranial pressure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypertonic Saline (Hypertonic saline)
  • Mannitol (mannitol)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Elevated Intracranial Pressure | NA | Status: WITHDRAWN